Rudiger Klein

Title: The Innovative Contributions of Rudiger Klein

Introduction

Rudiger Klein is a prominent inventor based in Nussloch, Germany. He is known for his significant contributions to the field of neuroscience, particularly in the study of neurotrophin receptors. His work has implications for understanding neuronal degeneration and potential treatments for related diseases.

Latest Patents

Rudiger Klein holds a patent for "Mice deficient in nerve growth factor receptors encoded by trkB." This invention provides genetically modified mice and mouse cell lines that exhibit a deficiency in a gene encoding a neurotrophin receptor. Specifically, these mice carry a targeted mutation within the trkB locus, which affects their expression of the gp95.trkB receptor. The mutation leads to multiple deficiencies in the central and peripheral nervous systems, resulting in a postembryonic lethal phenotype. These genetically modified mice serve as valuable models for studying human diseases associated with neuronal degeneration and for screening potential therapeutic compounds.

Career Highlights

Rudiger Klein is affiliated with Bristol-Myers Squibb Company, where he continues to advance research in neuroscience. His work has garnered attention for its innovative approach to understanding the mechanisms of neuronal cell loss and regeneration.

Collaborations

Rudiger Klein has collaborated with notable scientists such as Mariano Barbacid and Alexandra Joyner. These collaborations have further enriched his research and contributed to the advancement of knowledge in the field.

Conclusion

Rudiger Klein's innovative work in the field of neuroscience, particularly through his patent on genetically modified mice, highlights his contributions to understanding neuronal health and disease. His ongoing research at Bristol-Myers Squibb continues to pave the way for future discoveries in this critical area of study.